SEL-24

DB18082InvestigationalSmall molecule

SEL-24: Overview.

Mechanism: Pharmacologically active on Receptor-type tyrosine-protein kinase FLT3, Serine/threonine-protein kinase pim-1, and Serine/threonine-protein kinase pim-3
Curator reviewed
Formula / weight: C₁₅H₁₈Br₂N₄O₂ · 446.143 g/mol (avg)
Also known as: 1h-benzimidazole, 5,6-dibromo-1-(1-methylethyl)-4-nitro-2-(4-piperidinyl)- · 5,6-dibromo-1-(1-methylethyl)-4-nitro-2-(4-piperidinyl)-1h-benzimidazole · 5,6-dibromo-4-nitro-2-(piperidin-4-yl)-1-(propan-2-yl)-1h-1,3-benzimidazole · Pim/flt3 kinase inhibitor sel24 · Sel-24 free base
Code names: SEL-24 · SEL24-B289

Resolves to

Compound

Structure

InChIKeyUOUBCIJIWDLRGM-UHFFFAOYSA-NSMILESCC(C)N1C(=NC2=C(C(Br)=C(Br)C=C12)[N+]([O-])=O)C1CCNCC1

Targets

What you can answer from here — as of September 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with SEL-24, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.